Page last updated: 2024-10-23

azathioprine and Pleural Effusion, Malignant

azathioprine has been researched along with Pleural Effusion, Malignant in 1 studies

Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.

Pleural Effusion, Malignant: Presence of fluid in the PLEURAL CAVITY as a complication of malignant disease. Malignant pleural effusions often contain actual malignant cells.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Nie, N1
Liu, Z1
Kang, J1
Li, L1
Cao, G1

Other Studies

1 other study available for azathioprine and Pleural Effusion, Malignant

ArticleYear
Multifocal pleural capillary hemangioma: a rare cause of hemorrhagic pleural effusion-case report.
    BMC pulmonary medicine, 2021, May-10, Volume: 21, Issue:1

    Topics: Administration, Oral; Adult; Azathioprine; Biopsy; Female; Hemangioma, Capillary; Hemothorax; Humans

2021